Endo International plc

NASDAQ:ENDP   3:59:54 PM EDT
5.90
+0.07 (+1.20%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.36B
Current PE5.50
Forward PE 2.8
2yr Forward PE 2.78
See more stats
Estimates Current Quarter
Revenue$681.01 Million
Adjusted EPS$0.47
See more estimates
10-Day MAN/A
50-Day MAN/A
200-Day MAN/A
See more pivots

Endo International plc Stock, NASDAQ:ENDP

Minerva House, Simmonscourt Road, Dublin, Dublin 4
Ireland
Phone: +353.1.268.2000
Number of Employees: 3397

Description

Endo International Plc operates as a pharmaceutical company. It focuses on developing, manufacturing, and distributing of branded and generic pharmaceutical products. The firm operates through the following segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals. The Branded Pharmaceuticals segment conducts certain operations in the U.S. through leased and owned manufacturing properties in Pennsylvania, New York and New Jersey, as well as certain administrative and R&D functions through leased properties in Pennsylvania. The Sterile Injectables segment conducts certain manufacturing, quality assurance, R&D and administration functions. The Generic Pharmaceuticals segment conducts certain manufacturing, distribution, quality assurance and administration functions, as well as certain R&D functions. The International Pharmaceuticals segmentâ??s operations are currently conducted through Paladinâ??s leased headquarters in Montreal, Canada. The company was founded in 1997 and is headquartered Dublin, Ireland.